Wednesday, August 5, 2026

Andrew Peller Ltd

Sound bite for Twitter is: Dividend Growth Consumer. Results of stock price testing is that the stock price is probably expensive. Debt Ratios are good. The Dividend Payout Ratios (DPR) are currently good. The current dividend yield is moderate with dividend growth low. See my spreadsheet on Andrew Peller Ltd.

Is it a good company at a reasonable price? Fairfax has offered to buy this stock at around $8.00 a share. A group led by Andrew Peller is rolling its shares into the buyer rather than selling their shares. See an article on Morningstar. If I know a stock I owned is being bought out, I sell. Why hold on for maybe months before you get your money and you can only generally get slightly more money.

I do not own this stock of Andrew Peller Ltd (TSX-ADW.A, OTC-ADWPF). This stock was on Mike Higgs' dividend growth stock list. I owned this stock as Andres Wines Ltd between 1996 and 2000. When I held this stock, it was called Andres Wines Ltd. I sold in 2000 and I only made a total return of 5.41% per year. Wh

en I was updating my spreadsheet, I noticed the stock climbed sharply in June 2026 and that was due to a definitive agreement to be acquired by Fairfax Financial Holdings Limited. After earnings losses in 2023 and 2024, the company had positive earnings in 2025. This year earnings are up 143% and higher than they were in 2021. There may be a Total Return loss over the 5 years to the end 2025, but the stock is up 50% year to date. Note that the financial year ends in 31 March each year, so I am reviewing the March 31, 2026 year end.

If you had invested in this company in December 2015, for $1,004.01 you would have bought 147 shares at $6.83 per share. In December 2025, after 10 years you would have received $320.77 in dividends. The stock would be worth $779.10. Your total return would have been $1,099.87. This would be a total return of 1.05% per year with 2.50% from capital loss and 3.55% from dividends.

Cost Tot. Cost Shares Years Dividends Stock Val Tot Ret
$6.83 $1,004.01 147 10 $320.77 $779.10 $1,099.87

The current dividend yield is moderate with dividend growth low. The current dividend yield is moderate (2% to4% ranges) at 3.08%. The 5 year median dividend yield is good (5% to 6% ranges) at 5.07%. The 10 year and historical median dividend yield is moderate at 2.41% and 3.84%. The dividends grew by a low amount (less than 8% per year) at 2.7% per year over the past 5 years. The main reason is that dividends have been flat for 3 years. The last dividend increase was in 2022 and it was for 9.04%.

The Dividend Payout Ratios (DPR) are currently good. The DPR for 2025 for Earnings per Share (EPS) is good at 40% with 5 year coverage too high at 121%. The DPR for 2025 for Adjusted Earnings per Share (AEPS) is good at 40% with 5 year coverage too high at 137%. The DPR for 2025 for Cash Flow per Share (CFPS) is good at 15% with 5 year coverage at 26%. The DPR for 2025 for Free Cash Flow (FCF) is good at 23% with 5 year coverage high at 50%.

Item Cur 5 Years
EPS 40.38% 120.95%
AEPS 39.55% 136.72%
CFPS 14.59% 26.20%
FCF 23.12% 50.16%

Debt Ratios are good. The Long Term Debt/Market Cap Ratio for 2025 is high at 0.63 and currently good at 0.39. The Liquidity Ratio for 2025 is good at 3.25 and 3.25 currently. The Debt Ratio for 2025 is good at 2.00 and 2.00 currently. The Leverage and Debt/Equity Ratios for 2025 are good at 2.00 and 1.00 and currently at 0.00 and 0.00. (They no longer have any debt.)

Type Year End Ratio Curr
Lg Term R 0.63 0.39
Intang/GW 0.38 0.23
Liquidity 3.25 3.25
Liq. + CF 4.20 3.75
Debt Ratio 2.00 2.00
Leverage 2.00 0.00
D/E Ratio 1.00 0.00

The Total Return per Year is shown below for years of 5 to 41 to the end of 2025. Under the Capital Gain column is the portion of the Total Return attributable to capital gains. Under the Dividend column is the portion of the Total Return attributable to dividends. See chart below.

From Years Div. Gth Tot Ret Cap Gain Div.
2020 5 2.71% -9.66% -12.75% 3.09%
2015 10 5.25% 1.05% -2.50% 3.55%
2010 15 5.51% 8.68% 4.02% 4.66%
2005 20 6.36% 6.95% 2.98% 3.97%
2000 25 5.06% 11.47% 6.04% 5.43%
1995 30 4.46% 9.72% 4.93% 4.78%
1990 35 3.81% 11.65% 4.97% 6.68%
1985 40 3.50% 6.45% 2.81% 3.64%
1984 41 7.61% 3.51% 4.10%

The 5-year low, median, and high median Price/Earnings per Share Ratios are 6.83, 7.80 and 8.76. The corresponding 10 year ratio of 12.87, 17.82 and 20.96. The corresponding historical ratios are 11.39, 13.12 and 14.71. The current ratio is 16.98 based on a stock price of $7.98 and EPS estimate for 2027 of $0.47. This ratio is between the low and median ratio of the 10 year median ratios. This stock price testing suggests that the stock price is relatively reasonable and below the median.

I also have Adjusted Earnings per Share data (AEPS). The 5-year low, median, and high median Price/Earnings per Share Ratios are 12.21, 15.40 and 18.59. The corresponding 10 year ratio of 13.24, 17.13 and 21.26. The corresponding historical ratios are 11.68, 14.65 and 16.08. The current ratio is 15.65 based on a stock price of $7.98 and EPS estimate for 2027 of $0.51. This ratio is between the low and median ratio of the 10 year median ratios. This stock price testing suggests that the stock price is relatively reasonable and below the median.

I get a Graham Price of $8.31. The 10-year low, median, and high median Price/Graham Price Ratios are 0.97, 1.29 and 1.67. The current ratio is 0.96 based on a stock price of $7.98. The current ratio is below the low ratio of the 10 year median ratio. This stock price testing suggests that the stock price is relatively cheap.

I get a 10-year median Price/Book Value per Share Ratio of 1.53. The current ratio is 1.33 based on a stock price of $7.98, Book Value of $264.3M and Book Value per Share of $6.02. The current ratio is 13% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively reasonable and below the median.

I get a 10-year median Price/Cash Flow per Share Ratio of 14.04. The current ratio is 7.98 based on Cash Flow per Share estimate for 2027 of $1.00, Cash Flow of $43.91 and a stock price of $7.98. The current ratio is 43% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively cheap.

I get an historical median dividend yield of 3.84%. The current dividend yield is 3.08% based on a stock price of $7.98 and Dividends of $0.25. The current dividend yield is 19.7% below the historical median ratio. This stock price testing suggests that the stock price is relatively reasonable but above the median.

I get a 10 year median dividend yield of 2.41%. The current dividend yield is 3.08% based on a stock price of $7.98 and Dividends of $0.25. The current dividend yield is 28% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively expensive.

The 10-year median Price/Sales (Revenue) Ratio is 1.05. The current P/S 0.89 based on a Revenue estimate for 2027 of $395.6M, Revenue per Share of $9.01 and a stock price of $7.9. The current ratio is 16% below the current P/S Ratio. This stock price testing suggests that the stock price is relatively reasonable and below the median.

Results of stock price testing is that the stock price is probably expensive. The dividend yield testing is saying the stock price is relatively expensive, but the P/S Ratio testing is saying that it is relatively reasonable. The rest of the testing ranges from cheap to reasonable but above the median.

When I look at analysts’ recommendations, I find one Hold (1). The consensus is a Hold. The 12 month consensus stock price is $8.00 with a high of $8.00 and a low of $8.00. This is the offer from Fairfax. The 12 month stock price consensus implies a total return of 3.33% with 0.25% from capital gains and 3.08% from dividends based on a current stock price of $7.98.

The one entry on Stock Chase for 2026 say Do Not Buy. Analyst says the company is fairly well run but it is in a tough area with thin margins and lots of taxes. Amy Legate-Wolfe on Motley Fool says to buy companies that can survive when costs rise. Christopher Liew on Motley Fool says that you should buy this company for passive income. The company put out a Press Release about their fourth quarter ending March 31, 2026. The company put out a Press Release about their first quarter of 2027.

The Canadian Press via Yahoo Finance put out a press release about Fairfax Financial Holdings Ltd buying Andrew Peller Ltd. Simply Wall Street via Yahoo Finance reviews this stock think this stock is worth keeping an eye on.

Andrew Peller Ltd is a wine-producing company. The company is engaged in the production, bottling, and marketing of wine, spirits, and craft beverage alcohol products in Canada. Its web site is here Andrew Peller Ltd.

The last stock I wrote about was about was BlackBerry Ltd (TSX-BB, NYSE-BB) ... learn more. The next stock I will write about will be Evertz Technologies Ltd (TSX-ET, OTC-EVTZF) ... learn more on Friday, August 7, 2026 around 5 pm. Tomorrow on my other blog I will write about Something to Buy August 2026 learn more on Thursday, July 2, 2026 around 5 pm.

This blog is meant for educational purposes only and is not to provide investment advice. I am not a licensed professional investment advisor. Before making any investment decision, you should always do your own research or consult an investment professional. I do research for my own edification and I am willing to share. I write what I think and I may or may not be correct.

See my site for an index to these blog entries and for stocks followed. I have three blogs. The first talks only about specific stocks and is called Investment Talk. The second one contains information on mostly investing and is called Investing Economics Mostly. My last blog is for my book reviews and it is called Non-Fiction Mostly. Follow me on Twitter. I am on Instagram. Or you can just Google #walktoronto spbrunner8166 to see my pictures.

Monday, August 3, 2026

BlackBerry Ltd

Sound bite for Twitter is: Canadian Tech Stock. Results of stock price testing is that the stock price is probably expensive. Debt Ratios are good. This stock never paid a dividend so there is no dividend yield or Dividend Payout Ratios (DPR). See my spreadsheet on BlackBerry Ltd.

Is it a good company at a reasonable price? Analysts’ recommendations are all over the place from Strong Buy to Sell. Analyst 12 months stock price is lower than the current stock price. You have to wonder if this will be a profitable company again. I am not interested in this at present. It would seem to be have a rather high price at this point.

I do not own this stock of BlackBerry Ltd (TSX-BB, NYSE-BB) but I used to. I bought this stock for capital gain. I first bought it in 1999 and then some more in 2000. I sold some in 2006 and 2007 to lock in some profit. I sold the rest of my stock in 2010. I had this stock for just over 10 years and a total return of 20.18% per year.

When I was updating my spreadsheet, I noticed that the stock price has climbed a lot recently and the stock price is up 132% to July 25, 2026. In this case if you had invested in this company in December 2016, for $1,000.62 you would have bought 109 shares at $9.18 per share. On July 25, 2026, after almost 10 years you would have received $0 in dividends. The stock would be worth $1,312.36. Your total return would have been $1,312.36. This would be a total return of 2.75% per year with 2.75% from capital gain and 0% from dividends. The total return for the last 5 years from December 2015 to December 2025 is less. See chart of total return below. There has not been a positive 5 year total return for quite some time. (Note that in August 2026, stock price has comedown a bit and 5 year total return is now on 2.65%)

Cost Tot. Cost Shares Years Dividends Stock Val Tot Ret
$9.18 $1,000.62 109 10 $0.00 $1,312.36 $1,312.36

I also noticed that all the officers I follow have bought more shares over the past years. None of the directors have and most of the directors, including the chairman have no shares at all. They all have Deferred Share Units. The last thing to mention is that analysts are all over place on their recommendations from Strong Buy to Sell.

Please note that the financial year for this stock ends at February 28 each year. I am looking at the February 28, 2026 fourth quarter financial results. The estimates are for the financial year ending in February 28, 2027. The financial statements and the estimates I found are all in US$.

This stock never paid a dividend so there is no dividend yield or Dividend Payout Ratios (DPR).

Debt Ratios are good. The Long Term Debt/Market Cap Ratio for 2025 is good at 0.10 and currently at 0.04. The Liquidity Ratio for 2025 is good at 2.12 and 2.10 currently. The Debt Ratio for 2025 is good at 2.49 and 2.49 currently. The Leverage and Debt/Equity Ratios for 2025 are good at 1.67 and 0.67 and currently at 1.67 and 0.67.

Type Year End Ratio Curr
Lg Term R 0.10 0.04
Intang/GW 0.81 0.32
Liquidity 2.12 2.10
Liq. + CF 2.27 2.27
Debt Ratio 2.49 2.49
Leverage 1.67 1.67
D/E Ratio 0.67 0.67

The Total Return per Year is shown below for years of 5 to 29 to the end of 2025 in CDN$. Under the Capital Gain column is the portion of the Total Return attributable to capital gains. Under the Dividend column is the portion of the Total Return attributable to dividends. See chart below.

From Years Div. Gth Tot Ret Cap Gain Div.
2020 5 0.00% -9.30% -9.30% 0.00%
2015 10 0.00% -8.68% -8.68% 0.00%
2010 15 0.00% -14.88% -14.88% 0.00%
2005 20 0.00% -7.67% -7.67% 0.00%
2000 25 0.00% -5.28% -5.28% 0.00%
1996 29 0.00% 5.15% 5.15% 0.00%

The Total Return per Year is shown below for years of 5 to 29 to the end of 2025 in US$. Under the Capital Gain column is the portion of the Total Return attributable to capital gains. Under the Dividend column is the portion of the Total Return attributable to dividends. See chart below.

From Years Div. Gth Tot Ret Cap Gain Div.
2020 5 0.00% -10.58% -10.58% 0.00%
2015 10 0.00% -8.57% -8.57% 0.00%
2010 15 0.00% -16.64% -16.64% 0.00%
2005 20 0.00% -8.42% -8.42% 0.00%
2000 25 0.00% -4.91% -4.91% 0.00%
1996 29 0.00% 5.15% 5.15% 0.00%

The 5-year low, median, and high median Price/Earnings per Share Ratios are negative and useless. The corresponding 10 year ratios are negative and useless. The corresponding historical ratio are 6.62, 11.95 and 15.48. The current ratio is 74.61 based on a stock price of $8.58 and EPS estimate for 2027 of $0.12. The current ratio is very high and would imply that the stock price is relatively expensive. This testing is in US$.

I also have Adjusted Earnings per Share (AEPS) data. The 5-year low, median, and high median Price/Adjusted Earnings per Share Ratios are 17.94, 23.16 and 28.38. The corresponding 10 year ratios are 39.84, 82.65 and 115.53. The corresponding historical ratio are 8.18, 17.25 and 28.38. The current ratio is 45.16 based on a stock price of $8.58 and AEPS estimate for 2027 of $0.19. The current ratio is between the low and median ratio of the 10 year median ratios. This stock price testing suggests that the stock price is relatively reasonable and below the median. This testing is in US$. These ratios are also very high.

I get a Graham Price of $3.24. The 10-year low, median, and high median Price/Graham Price Ratios are 1.98, 3.43 and 4.33. The current ratio is 3.69 based on a stock price of $11.93. The current ratio is between the median and high ratios of the 10 year median ratio. This stock price testing suggests that the stock price is relatively reasonable but above the median. This testing is in CDN$.

I get a 10-year median Price/Book Value per Share Ratio of 2.73. The current ratio is 6.95 based on Book Value of $725M, Book Value per Share of $1.23 and a stock price of $8.58. The current ratio is 154% above the 10 year median ratio. This stock price testing suggests that the stock price is relatively expensive. This testing is in US$.

I get a 10-year median Price/Cash Flow per Share Ratio of 7.91. The current ratio is 122.57 based on Cash Flow per Share estimate for 2027 of $0.07, Cash Flow of $41.1M and a stock price of $8.58. The current ratio is 1450% above the 10 year median ratio. This stock price testing suggests that the stock price is relatively expensive. This testing is in US$.

I cannot do any dividend yield testing as this stock does not have a dividend.

The 10-year median Price/Sales (Revenue) Ratio is 4.27. The current ratio is 8.20 based on Revenue estimate for 2027 of $614.5M, Revenue per Share of $1.05 and a stock price of $8.58. The current ratio is 92% above the 10 year median ratio. This stock price testing suggests that the stock price is relatively expensive. This testing is in US$.

Results of stock price testing is that the stock price is probably expensive. The P/S Ratio test is saying this. Another usually good test is the P/GP Ratio test that is saying that the stock price is reasonable but above the median. However, the P/GP Ratio are very high. A number of tests are saying that the stock price is relatively high.

When I look at analysts’ recommendations, I find Strong Buy (1), Buy (1), Hold (4), Underperform (1) and Sell (1). The consensus would be a Hold. The 12 month stock price consensus is $11.43 ($8.11 US$) with a High of $16.91 ($12.00 US$) and low of $7.44 ($5.28 US$). The 12 month consensus stock price of $11.43 implies a total loss of 4.20% based on a current stock price of $11.93.

There seems to be as many analysts on Stock Chase calling for a Sell as calling for a Buy. One analyst says that its overriding challenge is that it's a fallen champion. Stock Chase gives this stock 2 and one half stars out of 5. Karen Thomas on Motley Fool thinks that this stock is worth buying and holding for the Long Term. Christopher Liew on Motley Fool says it is now a software-growth story suited to investors seeking growth despite market turbulence. The company put out a Press Release about their fourth quarter ending in February 2026. The company put out a Press Release about their first quarter of 2027 ending in May 2026.

Zacks via Yahoo Finance reviews this stock. Vaishali Doshi says it started strong in fiscal year 2027, but can it deliver. Simply Wall Street via Yahoo Finance reviews this stock. They think it might be overvalued. They say some think it is undervalued and some think it is overvalued. They have one warning of Significant insider selling over the past 3 months. But that is options not taken up. All the officers I am following bought shares in the past year. However, I can only find one director with any shares. Mostly the directors have options.

BlackBerry, once known for being the world's largest smartphone manufacturer, is now exclusively a software provider with a stated goal of end-to-end secure communications for enterprises. Its web site is here BlackBerry Ltd.

The last stock I wrote about was about was Well Health Technologies Corp (TSX-WELL, OTCQX-WHTCF) ... learn more. The next stock I will write about will be Andrew Peller Ltd (TSX-ADW.A, OTC-ADWPF) ... learn more on Wednesday, August 5, 2026 around 5 pm. Tomorrow on my other blog I will write about Dividend Stocks August 2026.... learn more on Tuesday, June 30, 2026 around 5 pm.

This blog is meant for educational purposes only and is not to provide investment advice. I am not a licensed professional investment advisor. Before making any investment decision, you should always do your own research or consult an investment professional. I do research for my own edification and I am willing to share. I write what I think and I may or may not be correct.

See my site for an index to these blog entries and for stocks followed. I have three blogs. The first talks only about specific stocks and is called Investment Talk. The second one contains information on mostly investing and is called Investing Economics Mostly. My last blog is for my book reviews and it is called Non-Fiction Mostly. Follow me on Twitter. I am on Instagram. Or you can just Google #walktoronto spbrunner8166 to see my pictures.

Friday, July 31, 2026

Well Health Technologies Corp

Sound bite for Twitter is: Heath Care Sector stock. Results of stock price testing is that the stock price is probably cheap. Debt Ratios are mostly fine, but they need to improve their Liquidity Ratio. This stock has no dividends so no dividend yield and no Dividend Payout Ratios (DPR). See my spreadsheet on Well Health Technologies Corp.

Is it a good company at a reasonable price? I own this stock and I bought it with my fooling around money. I plan to keep this stock. It would seem that it is currently cheap.

I own this stock of Well Health Technologies Corp (TSX-WELL, OTCQX-WHTCF). I was interested in this stock when I heard it was to acquire Toronto based MyHealth Centers. CanTech Letter says that TSX stock investors can buy today is Well Health (TSX-WELL), a company that operates in the health-tech space. WELL stock has already returned over 4,000% to shareholders since its initial public offering in April 2016. No Dividend. See CanTech Letter.

When I was updating my spreadsheet, I noticed that this stock has not done much since I bought it last year. I have a loss of 12%.

If you had invested in this company in December 2015, for $1,007.24 you would have bought 26 shares at $38.74 per share. In December 2025, after 10 years you would have received $247.17 in dividends. The stock would be worth $2,547.22. Your total return would have been $2,794.39. This would be a total return of 11.26% per year with 9.72% from capital gain and 1.54% from dividends.

Cost Tot. Cost Shares Years Dividends Stock Val Tot Ret
$0.44 $1,000.12 2,273 8 $0.00 $9,069.27 $9,069.27

This stock has no dividends so no dividend yield and no Dividend Payout Ratios (DPR).

Debt Ratios are mostly fine, but they need to improve their Liquidity Ratio. The Long Term Debt/Market Cap Ratio for 2025 is good at 0.42 and currently at 0.45. The Liquidity Ratio for 2025 is low at 1.03 and far too low at 0.83 currently. If you added in Cash Flow after dividends, the ratios are still low at 1.37 and currently too low at 1.08. The Debt Ratio for 2025 is good at 1.98 and 1.94 currently. The Leverage and Debt/Equity Ratios for 2025 are fine at 2.43 and 1.22 and currently at 2.50 and 1.29.

Type Year End Ratio Curr
Lg Term R 0.42 0.45
Intang/GW 1.53 1.50
Liquidity 1.03 0.83
Liq. + CF 1.37 1.08
Debt Ratio 1.98 1.94
Leverage 2.43 2.50
D/E Ratio 1.22 1.29

The Total Return per Year is shown below for years of 5 to 8 to the end of 2025. Under the Capital Gain column is the portion of the Total Return attributable to capital gains. Under the Dividend column is the portion of the Total Return attributable to dividends. See chart below.

From Years Div. Gth Tot Ret Cap Gain Div.
2020 5 0.00% -13.10% -13.10% 0.00%
2017 8 0.00% 31.73% 31.73% 0.00%

The 5-year low, median, and high median Price/Earnings per Share Ratios are coming up 0 because of too many earnings losses in the years of the past 5 years. The corresponding 7 year ratios are all negative and so useless. Therefore, I can do not P/E Ratio testing.

I also have Adjusted Earnings per Share (AEPS) data. The 5-year low, median, and high median Price/Earnings per Share Ratios are 12.86, 19.50 and 26.14. The corresponding 8 year ratios are 9.22, 13.74 and 18.26. The current ratio is 16.83 based on AEPS estimate for 2026 of $0.24 and a stock price of $4.04. This ratio is between the median and high ratios of the 10 year median ratios. This stock price testing suggests that the stock price is relatively reasonable but above the median.

I get a Graham Price of $4.30. The 10-year low, median, and high median Price/Graham Price Ratios are 0.71, 1.08 and 1.26. The current ratio is 0.94 based on a stock price of $4.04. The current ratio is between the low and median ratios of the 10 year median ratios. This stock price testing suggests that the stock price is relatively reasonable and below the median.

I get a 10-year median Price/Book Value per Share Ratio of 1.52. The current ratio is 1.18 based on Book Value of $867.8M, Book Value per Share of $3.42 and a stock price of $4.04. The current ratio is 22% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively cheap.

I also have a Book Value per Share estimate for 2026 of $3.36. This produces a ratio of 1.20 with a Stock Price of $4.04 and a Book Value of $853M. This ratio is 20.8% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively cheap.

I get a 10-year median Price/Cash Flow per Share Ratio of 11.39. The current ratio is 8.88 based on Cash Flow per Share estimate for 2026 of $0.45, Cash Flow of $115.5M and a stock price of $4.04. The current ratio is 22% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively cheap.

I cannot do any dividend yield testing because this stock has no dividends.

The 10-year median Price/Sales (Revenue) Ratio is 2.02. The current ratio is 0.65 based on Revenue estimate for 2026 of $1590M, Revenue per Share of $6.26 and a Stock Price of $4.04. The current ratio is 68% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively cheap.

Results of stock price testing is that the stock price is probably cheap. The P/S Ratio test is saying this and it is confirmed by the P/GP Ratio test. The other tests say that the stock price is cheap to reasonable.

When I look at analysts’ recommendations, I find Strong Buy (8), Buy (4), and Hold (1). The consensus would be a Strong Buy. The 12 month stock price consensus is $7.18 with a high of $8.25 and low of $5.00. The consensus stock price of $7.18 implies a total return of $77.72% all from capital gains based on a current stock price of $4.04.

There is really a divergence of opinion on this stock on Stock Chase and quite a number of entries for 2026. One analyst says Do Not Buy because it tries to be a technology company but has yet to prove it and he sold. Another says Buy because it is an exciting growth play and not an if story, but a when story. Jitendra Parashar on Motley Fool thinks this stock could be a strong multi-year growth winner. Amy Legate-Wolfe on Motley Fool says this stock is a strong buy and that it is expanding fast in clinics and healthcare software. The company put out a Press Release about its fourth quarter results for 2025. The company put out a Press Release about its first quarter of 2026..

Simply Wall Street via Yahoo Finance reviews this stock. It says to own WELL, you need to believe that its mix of clinics, digital tools, and AI can justify today's valuation despite forecast earnings declines and integration risk. It has two warnings on this stock of interest payments are not well covered by earnings; and earnings are forecast to decline by an average of 12% per year for the next 3 years.

WELL Health Technologies Corp is a practitioner-focused digital healthcare company. Its web site is here Well Health Technologies Corp.

The last stock I wrote about was about was Stingray Digital Group Inc (TSX-RAY.A, OTC-STGYF) ... learn more. The next stock I will write about will be BlackBerry Ltd (TSX-BB, NYSE-BB) ... learn more on Monday, August 3, 2026 around 5 pm.

This blog is meant for educational purposes only and is not to provide investment advice. I am not a licensed professional investment advisor. Before making any investment decision, you should always do your own research or consult an investment professional. I do research for my own edification and I am willing to share. I write what I think and I may or may not be correct.

See my site for an index to these blog entries and for stocks followed. I have three blogs. The first talks only about specific stocks and is called Investment Talk. The second one contains information on mostly investing and is called Investing Economics Mostly. My last blog is for my book reviews and it is called Non-Fiction Mostly. Follow me on Twitter. I am on Instagram. Or you can just Google #walktoronto spbrunner8166 to see my pictures.

Also, on my book blog I have put a review of the book The Golden Road by William Dalrymple learn more...

Wednesday, July 29, 2026

Stingray Digital Group Inc

Sound bite for Twitter is: Dividend Paying Consumer. Results of stock price testing is that the stock price is probably on the expensive side. Debt Ratios need improving and the company has too much debt. The Dividend Payout Ratios (DPR) are good. The current dividend yield is moderate with dividend growth low. See my spreadsheet on Stingray Digital Group Inc.

Is it a good company at a reasonable price? There is a problem that they have not put out audited financial statements for their fourth quarter of March 31, 2026. I am using the unaudited results and this means that the audited values might be different. This is a problem. This is a risk. I am going to hold on to the stock I now have. I have not decided if I would buy any more. Analysts think that the stock will go up some 43% by next year. My testing is showing the stock price as relatively expensive.

I own this stock of Stingray Digital Group Inc (TSX-RAY, OTC-STGYF). I was following Newfoundland Capital Corp and Stingray bought them out. Also, I read the blub on CEO, Eric Boyko. The site says he is an entrepreneur with nearly two decades of experience with start-ups. Mr. Boyko has extensive expertise in early stage business innovations.

When I was updating my spreadsheet, I noticed I have done fine with this stock. It is with my fooling around money in my TFSA account. I first bought this in 2018 and then made purchases in 2019, 2021, 2022 and 2023. I have a total return of 16.86% with 13.59% from capital gains and 3.27% from dividends. This return is to the end of June 2026. Also note that this stock as a financial year ending March 31 each year, so I am looking at the fourth quarter dated March 31, 2026.

They have not put out audited Fourth Quarter results for their financial year ending March 31, 2026. I updated my spreadsheet from Supplemental Financial Information that they put out. Note that the stock price has gone up this year by 4.6%. The reason that they had an earning loss in 2026 is that they had a write-off for Impairment of Goodwill and Broadcast Licenses.

If you had invested in this company in December 2015, for $1,005.71 you would have bought 163 shares at $6.17 per share. In December 2025, after 10 years you would have received $439.29 in dividends. The stock would be worth $2,353.72. Your total return would have been $2,793.01. This would be a total return of 11.83% per year with 8.88% from capital gain and 2.95% from dividends.

Cost Tot. Cost Shares Years Dividends Stock Val Tot Ret
$6.17 $1,005.71 163 10 $439.29 $2,353.72 $2,793.01

The current dividend yield is moderate with dividend growth low. The current dividend yield is moderate (2% to 4% ranges) at 2.25%. The 5, 10 and historical dividend yields are moderate 4.12%, 3.91% and 3.71%. The dividend growth is low (below 8% per year) at just 1.30% per year over the past 5 years. The last dividend increase was in 2025 (and 2026 financial year) and it was for 13.33%. Dividends for the 5 years before had been flat.

The Dividend Payout Ratios (DPR) are good. The DPR for 2025 for Earnings per Share (EPS) is non-calculable due to an earnings loss with 5 year coverage high at 188%. The DPR for 2025 for Adjusted Earnings per Share (AEPS) is good at 24% with 5 year coverage at 33%. The DPR for 2025 for Adjusted Free Cash Flow (AFCF) is good at 21% with 5 year coverage at 26%. The DPR for 2025 for Cash Flow per Share (CFPS) is good at 17% with 5 year coverage at 18%. The DPR for 2025 for Free Cash Flow (FCF) is good at 25% with 5 year coverage at 30%.

Item Cur 5 Years
EPS 0.00% 187.65%
AEPS 24.06% 32.61%
AFCF 21.33% 26.10%
CFPS 17.02% 18.39%
FCF 25.37% 29.99%

Debt Ratios need improving and the company has too much debt. The Long Term Debt/Market Cap Ratio for 2025 is good at 0.51 and currently at 0.49. Note that a number of analysts do not like to see this ratio at 0.50 and above. The Liquidity Ratio for 2025 is too low at 0.79 and 0.79 currently. If you added in Cash Flow after dividends, the ratios are still low at 1.20 and currently better at 1.51. The Debt Ratio for 2025 is low at 1.26 and 1.26 currently. The Leverage and Debt/Equity Ratios for 2025 are much too high at 4.86 and 3.86 and currently at 4.86 and 3.86. I like to see these debt ratios below 3.00 and below 2.00.

Type Yr End Ratio Curr
Lg Term R 0.51 0.49
Intang/GW 0.77 0.73
Int less BL 0.51 0.49
Liquidity 0.79 0.79
Liq. + CF 1.20 1.51
Debt Ratio 1.26 1.26
Leverage 4.86 4.86
D/E Ratio 3.86 3.86

The Total Return per Year is shown below for years of 5 to 11 to the end of 2025. Under the Capital Gain column is the portion of the Total Return attributable to capital gains. Under the Dividend column is the portion of the Total Return attributable to dividends. See chart below.

From Years Div. Gth Tot Ret Cap Gain Div.
2020 5 1.30% 20.46% 16.99% 3.47%
2015 10 9.86% 11.83% 8.88% 2.95%
2014 11 8.93% 6.46% 2.46%

The 5-year low, median, and high median Price/Earnings per Share Ratios are 9.58, 13.22 and 16.86. The corresponding 10 year ratios are 11.32, 14.24 and 17.15. The corresponding historical ratios are 13.06, 15.25 and 17.45. The current ratio is 9.61 based on a stock price of $15.11 and EPS estimate for 2027 of $1.57. The current ratio is below the low ratio of the 10 year median ratios. This stock price testing suggests that the stock price is relatively cheap.

I also have Adjusted Earnings per Share (AEPS) data. The 5-year low, median, and high median Price/Earnings per Share Ratios are 5.73, 9.70 and 9.18. The corresponding 10 year ratios are 6.16, 8.46 and 10.54. The corresponding historical ratios are 6.16, 8.46 and 10.54. The current ratio is 7.33 based on a stock price of $15.11 and AEPS estimate for 2027 of $2.06. The current ratio is between the low ratio and median ratios of the 10 year median ratios. This stock price testing suggests that the stock price is relatively reasonable and below the median.

I also have Adjusted Free Cash Flow (AFCF) data. The 5-year low, median, and high median Price/Earnings per Share Ratios are 5.08, 6.32 and 7.64. The corresponding 10 year ratios are 5.27, 6.50 and 7.87. The corresponding historical ratios are 5.27, 6.50 and 7.87. The current ratio is 7.15 based on a stock price of $15.11 and AFCF estimate for 2027 of $2.11. The current ratio is between the median ratio and high ratios of the 10 year median ratios. This stock price testing suggests that the stock price is relatively reasonable but above the median.

I get a Graham Price of $12.01. The 10-year low, median, and high median Price/Graham Price Ratios are 0.75, 0.86 and 1.00. The current ratio is 1.26 based on a stock price of $15.11. This stock price testing suggests that the stock price is relatively expensive.

I get a 10-year median Price/Book Value per Share Ratio of 1.99. The current ratio is 4.86 based on a Book Value of $211.5M, Book Value per Share of $3.11 and a stock price of $15.11. The current ratio is 144% above the 10 year median ratio. This stock price testing suggests that the stock price is relatively expensive. Book Value went down this year because of an earnings loss.

I get a 10-year median Price/Cash Flow per Share Ratio of 5.76. The current ratio is 5.26 based on Cash Flow per Share estimate for 2027 of $2.87, Cash Flow of $195.2M and a stock price of $15.11. The current ratio is 8.6% below the 10 year ratio. This stock price testing suggests that the stock price is relatively reasonable and below the median.

I get an historical median dividend yield of 3.71%. The current dividend yield is 2.25% based on Dividends of $0.34 and a stock price of $15.11. The current dividend yield is 39% below the historical median dividend yield. This stock price testing suggests that the stock price is relatively expensive.

I get a 10 year median dividend yield of 3.91%. The current dividend yield is 2.25% based on Dividends of $0.34 and a stock price of $15.11. The current dividend yield is 42% below the 10 year median dividend yield. This stock price testing suggests that the stock price is relatively expensive.

The 10-year median Price/Sales (Revenue) Ratio is 1.78. The current P/S Ratio is 1.58 based on Revenue estimate for 2027 of $648.5M, Revenue per Share of $9.54 and a stock price of $15.11. The current ratio is 11% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively reasonable and below the median.

Results of stock price testing is that the stock price is probably on the expensive side. The 10 year median dividend yield test says this. The P/S Ratio test does not agree and it says that the stock price is reasonable and below the median. However, the P/GP Ratio test and P/B Ratio test, which are good tests, agree with the dividend yield test. Other tests show stock price as reasonable.

When I look at analysts’ recommendations, I find Strong Buy (3), and Buy (4). The consensus would be a Strong Buy. The 12 month stock price consensus is $21.36 with a high of $24.00 and a low of $20.00. The 12 month stock price consensus of $21.36 implies a total return of 43.61% with 41.36% from capital gains and 2.25% from dividends based on a current stock price of $15.11.

Last year, when I look at analysts’ recommendations, I found Strong Buy (3) and Buy (3). The consensus would be a Strong Buy. The 12 months target price given was $13.12 with a high of $13.50 and low of $13.00. The 12 month target price of $13.12 implies a total return of 28.91% with 26.03% from capital gains and 2.88% from dividends based on a current stock price of $10.72. What happened was a price increase to $15.11, a 40.95% increase so a Total return of 43.83% with 40.95% from capital gains and 2.88% from dividends based on a stock price of $10.72.

There is only one analyst recommendation on Stock Chase for 2026. It is a Top Pick. The previous entry was in 2023 and a Watch. Christopher Liew via Yahoo Finance on Motley Fool writes about this stock and says it has self-sustained momentum. The company put out a press release via Globe Newswire about their fourth quarter ending in March 2026.

Simply Wall Street via Yahoo Finance reviews this stock with regards to its dividend payments and says it can afford the dividend. Simply Wall Street has one warning of has a high level of debt. Simply Wall Street via Yahoo Finance reviewed this stock in May 2026 and thought the $14.79 price was too high for people to make a purchase of this stock..

Stingray Group Inc is a provider of multi-platform music services. It broadcasts music and video content on several platforms, including radio stations, premium television channels, digital TV, satellite TV, IPTV, the Internet, mobile devices, and game consoles. Geographically, the company derives its key revenue from Canada and the rest from the United States and other countries. Its web site is here Stingray Digital Group Inc.

The last stock I wrote about was about was Loblaw Companies Ltd (TSX-L, OTC-LBLCF) ... learn more. The next stock I will write about will be Well Health Technologies Corp (TSX-WELL, OTCQX-WHTCF) ... learn more on Friday, July 31, 2026 around 5 pm. Tomorrow on my other blog I will write about Sweden Buries Social Democracy.... learn more on Thursday, July 30, 2026 around 5 pm.

This blog is meant for educational purposes only and is not to provide investment advice. I am not a licensed professional investment advisor. Before making any investment decision, you should always do your own research or consult an investment professional. I do research for my own edification and I am willing to share. I write what I think and I may or may not be correct.

See my site for an index to these blog entries and for stocks followed. I have three blogs. The first talks only about specific stocks and is called Investment Talk. The second one contains information on mostly investing and is called Investing Economics Mostly. My last blog is for my book reviews and it is called Non-Fiction Mostly. Follow me on Twitter. I am on Instagram. Or you can just Google #walktoronto spbrunner8166 to see my pictures.

Monday, July 27, 2026

Loblaw Companies Ltd

Sound bite for Twitter is: Dividend Growth Consumer. Results of stock price testing is that the stock price is probably relatively expensive. Debt Ratios show that the company has too much debt. The Dividend Payout Ratios (DPR) are good. The current dividend yield is low with dividend growth moderate. See my spreadsheet on Loblaw Companies Ltd .

Is it a good company at a reasonable price? The stock price of this stock has risen sharply since around January 2021. I would worry that the growth in Revenue and Cash Flow is a lot lower than other growth, especially the stock price growth. Eventually, all growth depends on Revenue growth. I also do not like buying dividend stock when the dividend yield is below 1.00%. My testing is showing that on a lot of levels, the stock price is expensive as all tests point to this.

I do not own this stock of Loblaw Companies Ltd (TSX-L, OTC-LBLCF), but I did in the past. I owned it from 1996 to 2007. It was originally a great stock. I sold it in 2007 because it was having problems with its tech upgrade to its supply system and it did not seem that it would be fixed anytime soon. The stock started to do well again in 2014, but I had bought Metro and it has done well for me and it is a pure grocery stock. On the other hand, if I had bought more stock in 2007, I would have done very well with it to date. However, you never know how thing will work out.

When I was updating my spreadsheet, I noticed because of the problems this company had with its tech upgrade, shareholders who had this stock for 25 still have not reach a yearly return of at least 8%. From my spreadsheet, it looks like the stock hit a high in 2005 that was not duplicated until 2017, some 12 years later. The tech upgrade was their supply management system. I notice that if I cannot find a particular product in Metro, it will be there the next day. Loblaws stores might have it the next day or in two weeks’ time or somewhere in between.

What I have also noticed is that the stock price is climbing much faster than other values over the past 5 years. You can see that in the following chart in the 5 year figures where stock price is up 32% and the rest of the values show increases between 3.83% and 19.21%. What also stands out is the lack of revenue growth. In the chart below, I am showing 5 and 10 year total growth and per year growth in columns 3 and 4. Column 5 shows growth over 12 months to the first quarter in 2026 and expected growth over this year.

Yr Item Tot. Gwth Per Year Gwth Coverage
5 Revenue Growth 21.23% 3.92% 0.91% <-12 mths
5 AEPS Growth 132.54% 18.39% 2.06% <-12 mths
5 Net Income Growth 140.70% 19.21% 3.64% <-12 mths
5 Cash Flow Growth 20.67% 3.83% 5.67% <-12 mths
5 Dividend Growth 72.34% 11.50% 10.00% <-12 mths
5 Stock Price Growth 295.16% 31.63% 5.54% <-12 mths
10 Revenue Growth 40.77% 3.48% 2.77% <-this year
10 AEPS Growth 180.92% 10.88% 6.17% <-this year
10 Net Income Growth 321.99% 15.49% -0.19% <-this year
10 Cash Flow Growth 103.44% 7.36% 5.67% <-this year
10 Dividend Growth 121.70% 8.29% 11.83% <-this year
10 Stock Price Growth 279.86% 14.28% 8.62% <-this year

If you had invested in this company in December 2015, for $1,012.77 you would have bought 62 shares at $16.34 per share. In December 2025, after 10 years you would have received $227.68 in dividends. The stock would be worth $3,847.10. Your total return would have been $4,074.78. This would be a total return of 15.49% per year with 14.28% from capital gain and 1.21% from dividends. This calculation takes into consideration stock splits, which means that the original cost would be lowered by these splits. (They split the stock in 2025.)

Cost Tot. Cost Shares Years Dividends Stock Val Tot Ret
$16.34 $1,012.77 62 10 $227.68 $3,847.10 $4,074.78

The current dividend yield is low with dividend growth moderate. The current dividend yield is low (below 2%) at 0.95%. The 5, 10 and historical median dividend yields are also low at 1.45%, 1.49% and 1.45%. The dividend growth is moderate (8% to 14% ranges per year) at 11.5% per year over the past 5 years. The last dividend increase was 10% and it was in 2026.

The Dividend Payout Ratios (DPR) are good. The DPR for 2025 for Earnings per Share (EPS) is good at 25% with 5 year coverage at 29%. The DPR for 2025 for Adjusted Earnings per Share (AEPS) is good at 23% with 5 year coverage at 23%. The DPR for 2025 for Cash Flow per Share (CFPS) is good at 9% with 5 year coverage at 9%. The DPR for 2025 for Free Cash Flow (FCF) is good at 22% with 5 year coverage at 18%. FCF for 2025 varies from $2,049M, to $4,097M. I am using $3,580M.

Item Cur 5 Years
EPS 24.84% 28.77%
AEPS 22.69% 23.32%
CFPS 8.77% 8.67%
FCF 22.68% 17.97%

Debt Ratios show that the company has too much debt. The Long Term Debt/Market Cap Ratio for 2025 is good at 0.08 and currently at 0.08. The Liquidity Ratio for 2025 is low at 1.08 and 1.09 currently. If you added in Cash Flow after dividends, the ratios are still low at 1.48 and currently fine at 1.52. The Debt Ratio for 2025 is low at 1.37 and 1.36 currently. The Leverage and Debt/Equity Ratios for 2025 are too high at 3.71 and 2.71 and currently at 3.77 and 2.77.

Type Year End Ratio Curr
Lg Term R 0.08 0.08
Intang/GW 0.13 0.12
Liquidity 1.08 1.09
Liq. + CF 1.48 1.52
Debt Ratio 1.37 1.36
Leverage 3.71 3.77
D/E Ratio 2.71 2.77

The Total Return per Year is shown below for years of 5 to 37 to the end of 2025. Under the Capital Gain column is the portion of the Total Return attributable to capital gains. Under the Dividend column is the portion of the Total Return attributable to dividends. See chart below.

From Years Div. Gth Tot Ret Cap Gain Div.
2020 5 11.50% 33.30% 31.63% 1.67%
2015 10 8.29% 15.49% 14.28% 1.21%
2010 15 6.65% 14.24% 12.87% 1.36%
2005 20 4.95% 8.70% 7.69% 1.01%
2000 25 7.07% 7.50% 6.58% 0.93%
1995 30 10.51% 12.97% 11.19% 1.77%
1990 35 10.36% 12.81% 11.15% 1.65%
1988 37 9.92% 15.17% 12.87% 2.30%

The 5-year low, median, and high median Price/Earnings per Share Ratios are 16.96, 18.96 and 21.83. The corresponding 10 year ratios are 18.77, 22.52 and 25.39. The corresponding historical ratios are 17.05, 19.42 and 21.84. The current ratio is 28.85 based on a stock price of $65.49 and EPS estimate for 2026 of $2.27. The current ratio is above the high ratio of the 10 year median ratio. This stock price testing suggests that the stock price is relatively expensive. The ratios are pretty consistent, so this is a good test.

I also have Adjusted Earnings per Share (AEPS) data. The 5-year low, median, and high median Price/Earnings per Share Ratios are 14.27, 15.98 and 18.68. The corresponding 10 year ratios are 14.50, 16.10 and 18.36. The corresponding historical ratios are 13.64, 15.99 and 18.16. The current ratio is 25.38 based on a stock price of $65.49 and AEPS estimate for 2026 of $2.58. The current ratio is above the high ratio of the 10 year median ratio. This stock price testing suggests that the stock price is relatively expensive. The ratios are pretty consistent, so this is a good test.

I get a Graham Price of $23.21. The 10-year low, median, and high median Price/Graham Price Ratios are 1.16, 1.27 and 1.51. The current ratio is 2.82 based on a stock price of $65.49. The current ratio is above the high ratio of the 10 year median ratios. This stock price testing suggests that the stock price is relatively expensive.

I get a 10-year median Price/Book Value per Share Ratio of 2.33. The current ratio is 7.05 based on a Book Value of $10,909M, Book Value per Share of $9.28 and stock price of $65.49. The current ratio is 203% above the 10 year median ratio. This stock price testing suggests that the stock price is relatively expensive.

I also have Book Value per Share estimate of $9.57 for 2026. This value, with a stock price of $65.49 and book Value of $11,249M gives a ratio of 9.84. This ratio is 194% above the 10 year median ratio. This stock price testing suggests that the stock price is relatively expensive.

I get a 10-year median Price/Cash Flow per Share Ratio of 7.84. The current ratio is 11.63 based on Cash Flow for the last 12 months of $6,619M, Cash Flow per Share of $5.63 and a stock price of $65.49. The current ratio is 48% above the 10 year median ratio. This stock price testing suggests that the stock price is relatively expensive.

I get an historical median dividend yield of 1.45%. The current dividend yield is 0.95% based on a dividend of $0.620732 and a stock price of $65.49. The current dividend yield is 35% below the historical median dividend yield. This stock price testing suggests that the stock price is relatively expensive.

I get a 10 year median dividend yield of 1.49%. The current dividend yield is 0.95% based on a dividend of $0.620732. The current dividend yield is 36% below the 10 year median dividend yield. This stock price testing suggests that the stock price is relatively expensive.

The 10-year median Price/Sales (Revenue) Ratio is 0.60. The current P/S Ratio is 1.17 based on Revenue estimate for 2026 of $65,670M, Revenue per Share of $55.88 and a stock price of $65.49. The current ratio is 97% above the 10 year median ratio. This stock price testing suggests that the stock price is relatively expensive.

Results of stock price testing is that the stock price is probably relatively expensive. The Dividend yield tests say this and it is confirmed by the P/S Ratio test. In fact, all my tests are saying that the stock price is relatively expensive.

When I look at analysts’ recommendations, I find Strong Buy (5), Buy (3), Hold (1), and Sell (1). The consensus would be a Buy. The 12 month stock price consensus is $67.40 with a high of $75.00 and low of $43.00. The consensus stock price of $67.40 implies a total return of 3.86% with 2.92% from capital gains and 0.95% from dividends based on a current stock price of $65.49.

There are varies views on this company at Stock Chase. Some like it and call it a defensive stock. Other think it is expensive and other that its current growth is unsustainable. Amy Legate-Wolfe on Motley Fool thinks this is one of 5 top stocks to buy in August. Tony Dong on Motley Fool thinks this is a good stock to have as it will hold up in a Technical Recession. The company put out a press release via Globe Newswire about their fourth quarter of 2025 results. The company put out a press release via Globe Newswire about their first quarter of 2026.

Simply Wall Street on Yahoo Finance reviews this stock. They say it could be slightly below its fair value and at its fair value. They have one warning of has a high level of debt

Loblaw is Canada's largest retailer, operating approximately 2,500 food retail and pharmacy stores across the country. Beyond retail, Loblaw runs the PC Optimum loyalty program, but announced plans to sell its financial services arm including credit cards and insurance brokerage to EQB in December 2025. George Weston is Loblaw's controlling shareholder with a 53% stake. Its web site is here Loblaw Companies Ltd .

The last stock I wrote about was about was Savaria Corporation (TSX-SIS, OTC-SISXF) ... learn more. The next stock I will write about will be Stingray Digital Group Inc (TSX-RAY.A, OTC-STGYF) ... learn more on Wednesday, July 29, 2026 around 5 pm. Tomorrow on my other blog I will write about Pipelines but No Private Capital.... learn more on Tuesday, July 28, 2026 around 5 pm.

This blog is meant for educational purposes only and is not to provide investment advice. I am not a licensed professional investment advisor. Before making any investment decision, you should always do your own research or consult an investment professional. I do research for my own edification and I am willing to share. I write what I think and I may or may not be correct.

See my site for an index to these blog entries and for stocks followed. I have three blogs. The first talks only about specific stocks and is called Investment Talk. The second one contains information on mostly investing and is called Investing Economics Mostly. My last blog is for my book reviews and it is called Non-Fiction Mostly. Follow me on Twitter. I am on Instagram. Or you can just Google #walktoronto spbrunner8166 to see my pictures.

Friday, July 24, 2026

Savaria Corporation

Sound bite for Twitter is: Dividend Growth Consumer. Results of stock price testing is that the stock price is probably relatively expensive. Debt Ratios are good. The Dividend Payout Ratios (DPR) are currently mostly good. The current dividend yield is low with dividend growth low. See my spreadsheet on Savaria Corporation.

Is it a good company at a reasonable price? I agree with other analysts that this is a good company. However, my testing is showing that the stock is on the expensive side. The proper way to buy any stock is over time and in different months. I know that the analysts’ consensus is a Strong Buy, but almost all stocks all the time are Strong Buys. I would be cautious about buying at the present time.

I do not own this stock of Savaria Corporation (TSX-SIS, OTC-SISXF). I got this stock off the Dividend Blogger site that no longer exists. I am always interested in dividend growth small cap stock. The first few years of accounting were rather confusing, but I think I figured them out in the end.

This company has done very well over the past 5 and 10 years. It has had some good growth. In the chart below, I am showing 5 and 10 year total growth and per year growth in columns 3 and 4. Column 5 shows growth over 12 months to the first quarter in 2026 and expected growth over this year.

Yr Item Tot. Gwth Per Year Gwth Coverage
5 Revenue Growth 157.70% 20.84% 1.68% <-12 mths
5 AEPS Growth 116.07% 16.66% 9.09% <-12 mths
5 Net Income Growth 159.87% 21.05% 14.83% <-12 mths
5 Cash Flow Growth 180.05% 22.87% 3.28% <-12 mths
5 Dividend Growth 17.30% 3.24% 2.81% <-12 mths
5 Stock Price Growth 57.54% 9.52% 38.59% <-12 mths
10 Revenue Growth 858.95% 25.37% 6.96% <-this year
10 AEPS Growth 332.14% 15.76% 14.05% <-this year
10 Net Income Growth 668.90% 22.63% 44.54% <-this year
10 Cash Flow Growth 1038.50% 27.54% 12.44% <-this year
10 Dividend Growth 220.65% 12.36% 4.57% <-this year
10 Stock Price Growth 313.43% 15.25% 53.64% <-this year

If you had invested in this company in December 2015, for $1,002.82 you would have bought 182 shares at $5.51 per share. In December 2025, after 10 years you would have received $791.57 in dividends. The stock would be worth $4,145.96. Your total return would have been $4,937.53. This would be a total return of 19.40% per year with 15.25% from capital gain and 4.15% from dividends.

Cost Tot. Cost Shares Years Dividends Stock Val Tot Ret
$5.51 $1,002.82 182 10 $791.57 $4,145.96 $4,937.53

When I was updating my spreadsheet, I noticed for the three months ending in March 2026, the Sales went up 6.91% and expenses went down by 1.80%. Their EPS went from $0.17 quarter one last year to $0.31 quarter one this year. There are lots of positives about this stock, but I also noticed that the Dividend Payout Ratios (DPR) have gotten too high and the dividend increases are way down. However, the DPR looks like it will be at a reasonable level in 2026 and in moving forward.

The current dividend yield is low with dividend growth low. The current dividend yield is low (below 2%) at 1.83%. The 5, 10 and historical median dividend yields are moderate (2% to 4% ranges) at 2.81%, 2.77% and 3.32%. The dividend increases are low (below 8% per year) at 3% per year over the past 5 years. The last dividend increase was in 2025 and it was for 3.8%.

The Dividend Payout Ratios (DPR) are currently mostly good. The DPR for 2025 for Earnings per Share (EPS) is high at 57% with 5 year coverage at 88%. The DPR for 2025 for Adjusted Earnings per Share (AEPS) is good at 45% with 5 year coverage high at 79%. The DPR for 2025 for Cash Flow per Share (CFPS) is good at 25% with 5 year coverage at 28%. The DPR for 2025 for Free Cash Flow (FCF) is good at 38% with 5 year coverage at 47%.

Item Cur 5 Years
EPS 57.38% 87.74%
AEPS 45.05% 79.44%
CFPS 24.59% 28.37%
FCF 38.20% 46.68%

Debt Ratios are good. The Long Term Debt/Market Cap Ratio for 2025 is good at 0.10 and currently at 0.07. The Liquidity Ratio for 2025 is good at 1.61 and 1.71 currently. The Debt Ratio for 2025 is good at 2.40 and 2.44 currently. The Leverage and Debt/Equity Ratios for 2025 are good at 1.71 and 0.71 and currently at 1.69 and 0.69.

Type Year End Ratio Curr
Lg Term R 0.10 0.07
Intang/GW 0.39 0.29
Liquidity 1.61 1.71
Liq. + CF 2.15 2.33
Debt Ratio 2.40 2.44
Leverage 1.71 1.69
D/E Ratio 0.71 0.69

The Total Return per Year is shown below for years of 5 to 24 to the end of 2025. Under the Capital Gain column is the portion of the Total Return attributable to capital gains. Under the Dividend column is the portion of the Total Return attributable to dividends. See chart below.

From Years Div. Gth Tot Ret Cap Gain Div.
2020 5 3.24% 12.51% 9.52% 3.00%
2015 10 12.36% 19.40% 15.25% 4.15%
2010 15 13.28% 25.27% 19.47% 5.80%
2005 20 19.68% 16.20% 13.08% 3.12%
2001 24 10.95% 17.30% 14.41% 2.89%

The 5-year low, median, and high median Price/Earnings per Share Ratios are 21.69, 28.29 and 34.60. The corresponding 10 year ratios are 21.59, 27.18 and 34.74. The corresponding historical ratios are 14.64, 19.90 and 24.57. The current ratio is 22.29 based on a stock price of $30.54 and EPS estimate for 2026 of $1.37. The current ratio is between the low and median ratio of the 10 year median ratios. This stock price testing suggests that the stock price is relatively reasonable and below the median.

I also have Adjusted Earnings per Share (AEPS) data. The 5-year low, median, and high median Price/Earnings per Share Ratios are 18.85, 22.87 and 26.89. The corresponding 10 year ratios are 19.15, 24.48 and 30.01. The corresponding historical ratios are 14.54, 20.24 and 24.96. The current ratio is 22.13 based on a stock price of $30.54 and AEPS estimate for 2026 of $1.38. The current ratio is between the low and median ratio of the 10 year median ratios. This stock price testing suggests that the stock price is relatively reasonable and below the median.

I get a Graham Price of $16.88. The 10-year low, median, and high median Price/Graham Price Ratios are 1.20, 1.59 and 1.94. The current ratio is 1.81 based on a stock price of $30.54. The current ratio is between the median and high ratio of the 10 year median ratios. This stock price testing suggests that the stock price is relatively reasonable but above the median.

I get a 10-year median Price/Book Value per Share Ratio of 2.41. The current ratio is 3.33 based on a Book Value of $659.79M, Book Value per Share of $9.18 and a stock price of $30.54. The current ratio is 38% above the 10 year median ratio. This stock price testing suggests that the stock price is relatively expensive.

I get a 10-year median Price/Cash Flow per Share Ratio of 15.15. The current ratio is 14.14 based on Cash Flow per Share estimate for 2026 of $2.16, Cash Flow of $155.3M and a stock price of $30.54. The current ratio is 7% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively reasonable and below the median.

I get an historical median dividend yield of 3.32%. The current dividend yield is 1.83% based on dividends of $0.5604 and a stock price of $30.54. The current dividend yield is 45% below the historical median dividend yield. This stock price testing suggests that the stock price is relatively expensive.

I get a 10 year median dividend yield of 2.77%. The current dividend yield is 1.83% based on dividends of $0.5604 and a stock price of $30.54. The current dividend yield is 34% below the 10 year median dividend yield. This stock price testing suggests that the stock price is relatively expensive.

The 10-year median Price/Sales (Revenue) Ratio is 1.72. The current P/S Ratio is 2.25 based on a stock price of $30.54, Revenue estimate for 2026 of $977M and Revenue per Share of $13.59. The current ratio is 30% above the 10 year median ratio. This stock price testing suggests that the stock price is relatively expensive.

Results of stock price testing is that the stock price is probably relatively expensive. The dividend yield testing is saying that the stock price is relatively expensive and it is confirmed by the P/S Ratio test. The rest of the testing varies from reasonable to expensive. Other good test of P/GP Ratio and P/B Ratio is also saying that the stock price is relatively expensive.

When I look at analysts’ recommendations, I find Strong Buy (2), and Buy (6). The consensus would be a Strong Buy. The 12 month stock price consensus is $35.00 with a high of $37.00 and low of $33.00. The consensus 12 month stock price of $35.00 implies a total return of 16.44% with 14.60% from capital gains and 1.83% from dividends based on a current stock price of $30.54.

On Stock Chase in 2026 there are two entries of Partial Buy and Watch. The Watch analyst said it was hit by tariffs and is recovering and focused more on Europe than US now. Stock Chase gives this stock 4 and one half stars out of 5. Rajiv Nanjapla on Motley Fool thinks this is the ideal stock to build wealth in your TFSA account. Aditya Raghunath on Motley Fool thinks now is a good time to invest in this company. The company put out a Press Release about their fourth quarter of 2025. The company put out a Press Release about their first quarter of 2026.

Simply Wall Street via Yahoo Finance reviews this stock as an undervalued small cap. See the third stock reviewed. They say that the stock is undervalued as its current price is $16.53 and its fair value is $31.01. This was in May 2026. But this makes no sense as the stock price low in May 2026 was $27.00. Simply Wall Street has one warning of significant insider selling over the past 3 months. Often sites do not distinguish between not taking up options and selling. Over the past year the CEO, one officer and the Chairman have all increased their shares in this company.

Savaria Corp designs, engineers, and manufactures products for personal mobility. Its products include home elevators, wheelchair lifts, commercial elevators, ceiling lifts, stairlifts, and van conversions. The company's operating segments are Accessibility and Patient Care. The company derives maximum revenue from Accessibility segment. Its web site is here Savaria Corporation.

The last stock I wrote about was about was TECSYS Inc (TSX-TCS, OTC-TCYSF) ... learn more. The next stock I will write about will be Loblaw Companies Ltd (TSX-L, OTC-LBLCF) ... learn more on Monday, July 27, 2026 around 5 pm.

This blog is meant for educational purposes only and is not to provide investment advice. I am not a licensed professional investment advisor. Before making any investment decision, you should always do your own research or consult an investment professional. I do research for my own edification and I am willing to share. I write what I think and I may or may not be correct.

See my site for an index to these blog entries and for stocks followed. I have three blogs. The first talks only about specific stocks and is called Investment Talk. The second one contains information on mostly investing and is called Investing Economics Mostly. My last blog is for my book reviews and it is called Non-Fiction Mostly. Follow me on Twitter. I am on Instagram. Or you can just Google #walktoronto spbrunner8166 to see my pictures.